On 9/23/24, Rockwell Medical Inc (NASDAQ: RMTI) stock suffered a major decline of -10.9%, closing at $3.92. Moreover, this decline was accompanied by exceptionally high trading volume at 210% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 1.2% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, RMTI is expected to continue to be Value Creation neutral.
Rockwell Medical has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Rockwell Medical has a very low Appreciation Score of 3 but a very high Power Rating of 93, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment